Dollar supply has dried up ahead of Tuesday’s election in the east African nation
The SA workforce should look like the people who live in the country, not an enclave of a sensitive minority
KZN finance MEC Nomusa Dube-Ncube will replace Sihle Zikalala as premier, making her the first woman premier for the province
The deal, said to be valued at €600m, comes as global fertiliser prices are sky-high due to worries that the conflict between major exporters Russia and Ukraine could lead to food shortages
The ECB plans to rejig its corporate bond portfolio to favour issuers that pollute less.
Transnet, Telkom and Eskom estimate that thieves and vandals cost them a total of R7bn a year due to metal theft
Cuban officials are accepting international support in their fight to contain a massive fire at a fuel depot that has left at least 77 injured, 17 missing and sparked a mass evacuation from the area.
Every time All Black coach Ian Foster fronts the media, he presents it with denial, not truth and honest appraisal
The interior designer on timeless style and a feminine design sensibility
Geneva — More evidence is emerging that the Omicron coronavirus variant is affecting the upper respiratory tract, causing milder symptoms than previous variants, a World Health Organisation (WHO) official said on Tuesday.
"We are seeing more and more studies pointing out that Omicron is infecting the upper part of the body. Unlike the other ones, which could cause severe pneumonia," WHO incident manager Abdi Mahamud told Geneva-based journalists, saying it could be "good news".
However, he added that Omicron’s high transmissibility meant it would become dominant within weeks in many places, posing a threat in countries where a high portion of the population remained unvaccinated.
His remarks on the reduced risk of severe disease chimed with other data including a study from SA, which was one of the first countries in which Omicron was detected.
However, Mahamud also sounded a note of caution, calling SA an “outlier” since it has a young population, among other factors.
Asked about whether an Omicron-specific vaccine were needed, Mahamud said it was too early to say but stressed that the decision required global co-ordination and should not be left to the commercial sector to decide alone.
Would you like to comment on this article? Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.